MyFinsight
Home
Blog
About
Contact
Back
Income Statement
Sonoma Pharmaceuticals, Inc. (SNOA)
Sonoma Pharmaceuticals, Inc. (SNOA)
source: myfinsight.com
Comprehensive loss
-$2,042K
(60.04%↑ Y/Y)
Foreign currency
translation adjustments
$1,133K
(168.54%↑ Y/Y)
Net loss
-$3,175K
(8.16%↑ Y/Y)
Income tax benefit
(expense)
-$244K
(-144.36%↓ Y/Y)
Loss from operations
before income taxes
-$3,419K
(-17.61%↓ Y/Y)
Revenues
$19,529K
(36.68%↑ Y/Y)
Loss from operations
-$2,461K
(33.67%↑ Y/Y)
Other (expense)
income
-$958K
(-219.30%↓ Y/Y)
Gross profit
$7,415K
(35.68%↑ Y/Y)
Cost of revenues
$12,114K
(37.30%↑ Y/Y)
Total operating
expenses
$9,876K
(7.64%↑ Y/Y)
Selling, general and
administrative
$7,605K
(3.31%↑ Y/Y)
Research and development
$2,271K
(25.19%↑ Y/Y)
Back